A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies
Clinical trial NCT05048082 · COMPLETED
Trial details
- NCT number
- NCT05048082
- Sponsor
- OncoNano Medicine, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2022-08-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.